|
May 7
|
argenx to Present at BofA Securities 2024 Health Care Conference
|
|
Mar 26
|
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
|
|
Mar 22
|
Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday
|
|
Mar 22
|
Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last?
|
|
Mar 21
|
Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results
|
|
Mar 19
|
Reasons to Invest in argenx (ARGX)
|
|
Jan 12
|
How Argenx (ARGX) Stock Stands Out in a Strong Industry
|
|
Jan 2
|
argenx to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 22
|
UPDATE 2-European shares end slightly higher ahead of Christmas holiday
|
|
Dec 21
|
Immunovant Scores Much-Needed Win Following Argenx-Led Sell-off
|
|
Dec 21
|
argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study
|
|
Dec 20
|
Stock Market Does Sharp About-Face; Dow Breaks Win Streak
|
|
Dec 20
|
Argenx Crashes 25% As The Setbacks Mount For Its Hallmark Drug, Vyvgart
|
|
Dec 20
|
Argenx autoimmune drug study fails in blow to expansion hopes
|
|
Dec 20
|
argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus
|
|
Dec 18
|
argenx SE’s (ARGX) Share Price Increased By 28% Due to Several Factors
|
|
Dec 8
|
Why is Argenx (ARGX) a Suitable Investment Option?
|
|
Dec 3
|
12 Stocks Billionaire Steve Cohen Just Bought and Sold
|
|
Dec 1
|
Several Catalysts Pushed argenx SE (ARGX) in Q3
|
|
Nov 28
|
Argenx Stock Crashes On An Unexpected Failure For Its Biggest Drug
|